CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Equity Attributable to Breckenridge Prior to Acquisition	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at beginning of period at Dec. 31, 2021		$ 237	$ 155,268	$ (92,018)	$ (1,010)	$ 62,477
Balance at beginning of period (in shares) at Dec. 31, 2021		23,692,379
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	$ 1,806			(20,451)		(18,645)
Unrealized income (loss) on foreign exchange rate translation					(1,063)
Other comprehensive income (loss)					(1,063)	(1,063)
Issuance of common stock under stock compensation plans		$ 1	(1)
Issuance of common stock under stock compensation plans (in shares)		155,000
Stock-based compensation expense			413			413
Shares exchanged for taxes on stock-based compensation			(79)			(79)
Shares exchanged for taxes on stock-based compensation (in shares)		(35,050)
Cash settlement of RSUs			(301)			(301)
Treasury stock sale			113			113
Deemed contribution of Breckenridge net assets	6,472					6,472
Breckenridge cash distributions prior to acquisition	(583)					(583)
Balance at end of period at Dec. 31, 2022	7,695	$ 238	155,413	(112,469)	(2,073)	$ 48,804
Balance at end of period (in shares) at Dec. 31, 2022		23,812,329				23,812,329
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)	(976)			(11,171)		$ (12,147)
Unrealized income (loss) on foreign exchange rate translation					161
Other comprehensive income (loss)					161	161
Issuance of stock for Breckenridge acquisition	(1,335)	$ 12	2,008			685
Issuance of stock for Breckenridge acquisition (in shares)		1,188,235
Excess of purchase price over net assets acquired			(10,565)			(10,565)
Breckenridge cash distributions prior to acquisition	(3,055)					(3,055)
Deemed distributions of Breckenridge net assets not acquired	$ (2,329)					(2,329)
Issuance of stock for convertible note		$ 58	9,822			9,880
Issuance of stock for convertible note (in shares)		5,811,765
Balance at end of period at Dec. 31, 2023		$ 308	$ 156,678	$ (123,640)	$ (1,912)	$ 31,434
Balance at end of period (in shares) at Dec. 31, 2023		30,812,329				30,812,329